RDHL vs TAK
RedHill Biopharma Ltd. · Takeda Pharmaceutical Company Limited
Relative return (rebased to 100)
Key stats
| Metric | RDHL | TAK |
|---|---|---|
| Price | $0.38 | $21.12 |
| Market Cap | $19.41B | $33.60B |
| P/E | — | — |
| P/B | — | — |
| P/S | 2412.89 | — |
| ROE | — | — |
| Net Margin | -102.8% | — |
| Gross Margin | 60.3% | — |
| Revenue Growth | 23.2% | — |
| Dividend Yield | — | — |
| EPS | -$0.00 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.